Premium
Solar urticaria induced by visible light: successful treatment with omalizumab
Author(s) -
Terrani I.,
Bircher A. J.,
Scherer Hofmeier K.
Publication year - 2016
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.12951
Subject(s) - omalizumab , medicine , dermatology , immunoglobulin e , immunology , antibody
Summary We report the case of a 53‐year‐old man with solar urticaria ( SU ) not responding to histamine antagonist therapy. Using intradermal testing with the patient's irradiated serum, we demonstrated that his SU was elicited by visible light only. This type of SU is uncommon, and makes preventive measures such as sun block largely ineffective. However, the patient had an extraordinary response to the treatment with omalizumab. This case report highlights the diagnostic process and the success of omalizumab for the treatment of SU after 16 months of follow‐up.